A robust safety signal detection program is critical to any clinical development program. It is important that sponsors are able to monitor trends across indications and studies in order to act proactively and responsibly to mitigate risks and ensure patient safety in clinical trials.

Why ACI?
Through its expert committees and supporting technologies, ACI can help support Safety Signal Detection through a programmatic approach that highlights these safety signals in an easy-to-review clinical format for a sponsor’s safety team.

We establish Data Transfer Agreements from all active study CROs and upon receipt of the data, compile, code and format a safety signal report for your review on an ongoing basis.

If you have a safety surveillance plan already in place, we can tailor our detection to your plan’s requirement.